CCBE1 Gene Hennekam lymphangiectasia-lymphedema syndrome type 1 Genetic Test
Genetic testing plays a crucial role in diagnosing and understanding rare genetic disorders. One such disorder is Hennekam lymphangiectasia-lymphedema syndrome type 1, which is associated with the CCBE1 gene.
The CCBE1 gene is responsible for lymphangiectasia, which refers to the abnormal dilation of lymphatic vessels, and lymphedema, which is the swelling caused by impaired lymphatic drainage. To diagnose this syndrome, a genetic test called CCBE1 Gene Hennekam lymphangiectasia-lymphedema syndrome type 1 Genetic Test is available.
The cost of this test is AED 4400.0. The test can be conducted using a blood sample, extracted DNA, or one drop of blood on an FTA card. The report delivery time is typically 3 to 4 weeks. The method used for this test is NGS (Next-Generation Sequencing) technology.
The CCBE1 Gene Hennekam lymphangiectasia-lymphedema syndrome type 1 Genetic Test falls under the Osteology Dermatology Immunology Disorders category and is conducted by dermatologists in the Genetics department.
Prior to the test, it is important to provide the clinical history of the patient and undergo a genetic counseling session. This session helps in drawing a pedigree chart of family members affected by CCBE1 Gene Hennekam lymphangiectasia-lymphedema syndrome type 1 NGS Genetic DNA Test gene CCBE1.
NGS genetic testing is a comprehensive method that allows the simultaneous analysis of multiple genes. In the context of Hennekam lymphangiectasia-lymphedema syndrome type 1, NGS testing helps identify mutations or variations in the CCBE1 gene that may be responsible for the disorder.
By sequencing the DNA of an individual, NGS testing confirms a diagnosis, determines the inheritance pattern, and provides information for genetic counseling. However, it is essential to consult with a healthcare professional or genetic counselor to understand the benefits, limitations, and implications of NGS genetic testing for Hennekam lymphangiectasia-lymphedema syndrome type 1.
| Test Name | CCBE1 Gene Hennekam lymphangiectasia-lymphedema syndrome type 1 Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Osteology Dermatology Immunology Disorders |
| Doctor | Dermatologist |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for CCBE1 Gene Hennekam lymphangiectasia-lymphedema syndrome type 1 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with CCBE1 Gene Hennekam lymphangiectasia-lymphedema syndrome type 1 NGS Genetic DNA Test gene CCBE1 |
| Test Details |
The CCBE1 gene is associated with a rare genetic disorder called Hennekam lymphangiectasia-lymphedema syndrome type 1. This syndrome is characterized by lymphangiectasia (abnormal dilation of lymphatic vessels) and lymphedema (swelling due to impaired lymphatic drainage). NGS (Next-Generation Sequencing) genetic testing is a method used to analyze multiple genes simultaneously. In the context of Hennekam lymphangiectasia-lymphedema syndrome type 1, NGS genetic testing can be used to identify mutations or variations in the CCBE1 gene that may be responsible for the disorder. NGS testing involves sequencing the DNA of an individual to identify any genetic changes in the CCBE1 gene. This can help in confirming a diagnosis, determining the inheritance pattern, and providing information for genetic counseling. It is important to consult with a healthcare professional or genetic counselor to discuss the benefits, limitations, and implications of NGS genetic testing for Hennekam lymphangiectasia-lymphedema syndrome type 1. |
